<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8C60EACC-2042-4C1A-B611-814952374BA5"><gtr:id>8C60EACC-2042-4C1A-B611-814952374BA5</gtr:id><gtr:name>Faculty of Medicine, Dentistry and Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Centre for Brain Repair</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8C60EACC-2042-4C1A-B611-814952374BA5"><gtr:id>8C60EACC-2042-4C1A-B611-814952374BA5</gtr:id><gtr:name>Faculty of Medicine, Dentistry and Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6D96679F-7B87-4095-8643-EDEC89A16D03"><gtr:id>6D96679F-7B87-4095-8643-EDEC89A16D03</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Ince</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E3406FFA-68B6-49BB-A34C-5A9008DA9B5A"><gtr:id>E3406FFA-68B6-49BB-A34C-5A9008DA9B5A</gtr:id><gtr:firstName>Pamela</gtr:firstName><gtr:otherNames>Jean</gtr:otherNames><gtr:surname>Shaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AD1822BB-1BB1-4615-A1F4-C09974D60E25"><gtr:id>AD1822BB-1BB1-4615-A1F4-C09974D60E25</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Lowe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/17305919-543E-4873-9BFB-D9ABEE8856A1"><gtr:id>17305919-543E-4873-9BFB-D9ABEE8856A1</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Layfield</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FB1268E6-53F8-4C6D-BBA3-C8D455ED63C4"><gtr:id>FB1268E6-53F8-4C6D-BBA3-C8D455ED63C4</gtr:id><gtr:firstName>Maria Grazia</gtr:firstName><gtr:surname>Spillantini</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0301152"><gtr:id>57327D52-44AC-4D21-A60E-C34CE803134E</gtr:id><gtr:title>Characterization of ubiquitin inclusions in FTD-MND and MND</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301152</gtr:grantReference><gtr:abstractText>The Sheffield and Nottingham groups are directly involved with patient groups through the MNDA funded Care and Research Centres in those cities. The applicants will use the MNDA national and local meetings to present this work to carers and patients. Successful application of proteomic techniques to unlock the key molecular events in a human brain disease by using archival tissue will be of major interest in the general scientific media in terms of the current UK debate about the use of human tissues in research. The applicants will seek to bring any success in the project to general press attention.</gtr:abstractText><gtr:technicalSummary>Neurodegeneration in the ageing CNS is characterised by protein dysmetabolism and the presence of protein aggregates. This process appears directly related to cell death and CNS dysfunction. Neurodegenerative diseases that were once defined solely on clinico-pathological grounds are increasingly assimilated into a classification based on the underlying protein dysmetabolism. These include tau (Alzheimer s disease, frontotemporal dementia/parkinsonism ch17 syndromes[FTDP-17], progressive supranuclear palsy, corticobasal degeneration etc.), alpha-synuclein (Parkinson s disease, Dementia with Lewy bodies, Multiple system atrophy etc), and a variety of other proteins associated with less common disorders (e.g. neurofilament, trinucleotide repeat expansion proteins etc.). They are all characterised by intracellular inclusions, predominantly composed by one of these proteins. The protein dysmetabolism almost invariably includes aggregation and fibrilisation which can be associated with ubiquitin-related protein metabolism, so that ubiquitin is variably co-localised to the inclusion bodies. 
Amyotrophic lateral sclerosis (ALS) and related disorders remain outside this new molecular understanding because the underlying protein dysmetabolism has not been defined. This group of disorders are characterised by ubiquitylated inclusions (UBI) within neurons but the identity of the inclusion body protein(s) has not been elucidated by immunochemical, genetic or other strategies. Developments in several areas of science including understanding of the relationship between ALS and other disorders, microdissection technology, and diverse novel proteomic analytical approaches present a timely opportunity to investigate the identity of the UBI protein. 
The significance of this problem could not be overstated for the field of ALS research. ALS genetics has, unlike for tau and a-synuclein, failed to deliver this data in either sporadic or familial disease. For the other common neurodegenerative diseases listed above knowledge of the pathogenesis of inclusion body formation has been the major impetus for research advances in the last decade. We propose a collaborative, interdisciplinary approach applied to human tissue samples and using proven, cutting-edge methods allied to expert clinical and pathological data to identify the protein present in UBI in ALS and frontotemporal dementia with ALS.</gtr:technicalSummary><gtr:fund><gtr:end>2008-08-19</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-20</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>348047</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine, Dentistry and Health</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neuroscience</gtr:department><gtr:description>Protein characterization in ALS and FTD.</gtr:description><gtr:id>80397749-28FD-41A0-B123-3F612D62DB65</gtr:id><gtr:impact>papers in the grant</gtr:impact><gtr:partnerContribution>Prof P. Ince and P. Shaw were co-applicant in the grant, they provided tissue from ALS and FTD patients and we discussed the results</gtr:partnerContribution><gtr:piContribution>We extracted proteins from tissue and run blots and mass spect</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical Neurosciences</gtr:department><gtr:description>Clinical, genetic and pathological characterization of FTD cases</gtr:description><gtr:id>414780E3-7ED5-4CBF-925A-935A7EC5C5F1</gtr:id><gtr:impact>the output is shown by papers published with Prof John Hodges</gtr:impact><gtr:partnerContribution>providing brains from patients clinically well characterised</gtr:partnerContribution><gtr:piContribution>investigated tau genetics and molecular pathological features</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to the Italian Society of Frontotemporal dementia lay members</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F90A3DB5-4DE7-44E8-9B2F-0D70EBEDD9C5</gtr:id><gtr:impact>Presentation of results on frontotemporal dementia study</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conferences, patient groups, public seminars</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2A745EFB-ABAA-4FBF-955B-81782CBBE155</gtr:id><gtr:impact>Presented data at various types of meetings

Further collaborations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Student organisation conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6ADACDB2-F033-4F95-91D3-70043284B782</gtr:id><gtr:impact>I was invited to give a plenary lecture at the Meeting organised by London universities postgraduate student association</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to the Italian Cultural association &quot;Il Circolo&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EEA9BE66-ECB6-4F04-84BE-108B982C39A2</gtr:id><gtr:impact>Invited to give a talk to a general audience on the state of art on Parkinson's and frontotemporal dementia to member of the public.

The attendee were excited by the result of our research and organised a small fund raising to support a 6 month visit from an Italian postdoctoral fellow.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Target Validation</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:id>48BA9309-0158-4EF3-A739-070B6CCA5EF1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Isaac Newton Trust</gtr:department><gtr:description>Project Grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>7E2DD8B7-AE99-4210-B5C1-9040FBE34437</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>288816</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Fellowship</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>1B95C095-62E9-4500-8D0B-7B1F5E6F2607</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>325236</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>C3FE4333-C26B-4C99-A356-25F51CED0945</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Dr. Scholl Foundation</gtr:fundingOrg><gtr:id>0D89D3B7-2C6A-4744-BE5D-B04B2F647820</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>247900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>0454B2D1-42AE-4927-8888-394AC3CB52BF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>421800</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Collaboration grant</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:fundingRef> Promotion of plasticity as a treatment for neurodegenerative conditions.</gtr:fundingRef><gtr:id>87EBFBEC-7814-4CE4-B762-B81CAE44156A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Cambridge Home &amp; EU Scholarship Scheme (CHESS)</gtr:department><gtr:description>PhD Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>CC68A387-07C5-45A4-A790-99BB19EE4E72</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2127000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre Grant</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Multiple Sclerosis Society</gtr:fundingOrg><gtr:id>9F0E3180-7D56-4339-B80F-6FCBF9C02695</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:fundingOrg><gtr:id>F27E097C-AD99-4076-8F1F-72F5F09D9E7F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FENS School on Neurodegenerative diseases</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EFC01304-CDF9-4DE0-8FD7-D9DDB3015072</gtr:id><gtr:impact>The school was attended by students from different countries, some under-developed and the possibility was given to these students to be part of the international scientific community</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>human brain and spinal cord tissue</gtr:description><gtr:id>A4319789-89D2-44A1-8DA6-F6C11A3F8AC9</gtr:id><gtr:impact>knowledge of the type of pathology present in frontotemporal dementia</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>charcaterization of Brain pathology</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C57F6117-52E5-4F69-9B0D-B659A28B6C7C"><gtr:id>C57F6117-52E5-4F69-9B0D-B659A28B6C7C</gtr:id><gtr:title>Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5f0442ffcdcd359cb84f7e73b5cdf13"><gtr:id>a5f0442ffcdcd359cb84f7e73b5cdf13</gtr:id><gtr:otherNames>Rittman T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92501E0A-CCEF-43FE-ADBC-61F7D413AA49"><gtr:id>92501E0A-CCEF-43FE-ADBC-61F7D413AA49</gtr:id><gtr:title>Closing the tau loop: the missing tau mutation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19697c88f4ed271d133d545de9bd6f47"><gtr:id>19697c88f4ed271d133d545de9bd6f47</gtr:id><gtr:otherNames>McCarthy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BAAFEAA4-DF5D-4454-9721-F99CE02A3933"><gtr:id>BAAFEAA4-DF5D-4454-9721-F99CE02A3933</gtr:id><gtr:title>Phenotypic variation of autosomal-dominant corticobasal degeneration.</gtr:title><gtr:parentPublicationTitle>European neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66226cd2754860bbd586d06d07127b03"><gtr:id>66226cd2754860bbd586d06d07127b03</gtr:id><gtr:otherNames>Jung HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-3022</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AEBDD27-66D5-4C62-AEE3-B147872B1CDB"><gtr:id>3AEBDD27-66D5-4C62-AEE3-B147872B1CDB</gtr:id><gtr:title>Interaction of tau protein with the dynactin complex.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68c68014486053b53c7b0a5098c6ad3e"><gtr:id>68c68014486053b53c7b0a5098c6ad3e</gtr:id><gtr:otherNames>Magnani E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3704E9F5-B637-468B-95F4-77D971543B64"><gtr:id>3704E9F5-B637-468B-95F4-77D971543B64</gtr:id><gtr:title>Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9fcee6ba470208405b0174689bd2cf0"><gtr:id>f9fcee6ba470208405b0174689bd2cf0</gtr:id><gtr:otherNames>Bellucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8FB0DC6-044F-484E-ADEF-3F54086D5BE1"><gtr:id>D8FB0DC6-044F-484E-ADEF-3F54086D5BE1</gtr:id><gtr:title>Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d30dd2e2ed78c0043db7c3e39b94426"><gtr:id>1d30dd2e2ed78c0043db7c3e39b94426</gtr:id><gtr:otherNames>Pereira JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96608A50-A24C-4477-B86A-AA8D21445E7C"><gtr:id>96608A50-A24C-4477-B86A-AA8D21445E7C</gtr:id><gtr:title>Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e51d66455c2ba12f51e2a70dc81e482b"><gtr:id>e51d66455c2ba12f51e2a70dc81e482b</gtr:id><gtr:otherNames>Hodges JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43B67B43-5942-4A85-9E4E-E763065E8CEE"><gtr:id>43B67B43-5942-4A85-9E4E-E763065E8CEE</gtr:id><gtr:title>Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/80d90ee46f35a4a33c5823afc4f87b66"><gtr:id>80d90ee46f35a4a33c5823afc4f87b66</gtr:id><gtr:otherNames>Van Deerlin VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CD1F878-FBFC-4A0D-B942-3BF186B33B44"><gtr:id>2CD1F878-FBFC-4A0D-B942-3BF186B33B44</gtr:id><gtr:title>Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fc21c9450240b501767f99170e5fd42"><gtr:id>4fc21c9450240b501767f99170e5fd42</gtr:id><gtr:otherNames>Anfossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8C6243B-F87F-4F5C-9703-D18A3F7C085C"><gtr:id>E8C6243B-F87F-4F5C-9703-D18A3F7C085C</gtr:id><gtr:title>Tau pathology and neurodegeneration.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9a459db5eb95e716cced7a352cee42f"><gtr:id>f9a459db5eb95e716cced7a352cee42f</gtr:id><gtr:otherNames>Spillantini MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9019541E-9DF7-4CA9-B482-76BDFCAA06E5"><gtr:id>9019541E-9DF7-4CA9-B482-76BDFCAA06E5</gtr:id><gtr:title>Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8aeb6b28b8c92ecd7ba0d456ecc1522"><gtr:id>d8aeb6b28b8c92ecd7ba0d456ecc1522</gtr:id><gtr:otherNames>Iovino M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6387CC5-26AB-40E1-865A-E3C585D03618"><gtr:id>D6387CC5-26AB-40E1-865A-E3C585D03618</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C8C2D23-1405-4FE3-AD58-48E794AD6F16"><gtr:id>9C8C2D23-1405-4FE3-AD58-48E794AD6F16</gtr:id><gtr:title>Unpicking frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ce6eeacfdcd5222747dab3fa256a93b"><gtr:id>1ce6eeacfdcd5222747dab3fa256a93b</gtr:id><gtr:otherNames>Love S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE369AE7-5437-4438-A294-035FCF46C5E6"><gtr:id>FE369AE7-5437-4438-A294-035FCF46C5E6</gtr:id><gtr:title>Slowly progressive behavioural presentation in two UK cases with the R406W MAPT mutation.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/22774ec6f2faee7289c98bc217c42aa5"><gtr:id>22774ec6f2faee7289c98bc217c42aa5</gtr:id><gtr:otherNames>Wood R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34466994-84C7-4068-8102-D6C2ACECD4EE"><gtr:id>34466994-84C7-4068-8102-D6C2ACECD4EE</gtr:id><gtr:title>A century of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/757F98C1-E9B2-435E-B842-F41B8FFDD086"><gtr:id>757F98C1-E9B2-435E-B842-F41B8FFDD086</gtr:id><gtr:title>Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/294B66FC-1E11-470A-980F-0790ED084113"><gtr:id>294B66FC-1E11-470A-980F-0790ED084113</gtr:id><gtr:title>The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8aeb6b28b8c92ecd7ba0d456ecc1522"><gtr:id>d8aeb6b28b8c92ecd7ba0d456ecc1522</gtr:id><gtr:otherNames>Iovino M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1832A895-1C01-40AA-8FFA-48CF06E8418B"><gtr:id>1832A895-1C01-40AA-8FFA-48CF06E8418B</gtr:id><gtr:title>Frontotemporal lobar degeneration through loss of progranulin function.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67409563-B4BD-4F85-9524-7D8CCEB94992"><gtr:id>67409563-B4BD-4F85-9524-7D8CCEB94992</gtr:id><gtr:title>PART is part of Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13366f5b3cf608c475c69e5e2657b3fd"><gtr:id>13366f5b3cf608c475c69e5e2657b3fd</gtr:id><gtr:otherNames>Duyckaerts C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4C0D06F-133D-432B-AD86-BDCD6777908F"><gtr:id>C4C0D06F-133D-432B-AD86-BDCD6777908F</gtr:id><gtr:title>Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f4389c03dd4b6b448bad5879d383a048"><gtr:id>f4389c03dd4b6b448bad5879d383a048</gtr:id><gtr:otherNames>Xiong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0218D364-21FE-4F5A-B92A-7A17D1E68456"><gtr:id>0218D364-21FE-4F5A-B92A-7A17D1E68456</gtr:id><gtr:title>The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c57fe98a7077ec4da99908912e27085"><gtr:id>3c57fe98a7077ec4da99908912e27085</gtr:id><gtr:otherNames>Spina S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9241FF20-A237-430B-915F-CDA865D7698E"><gtr:id>9241FF20-A237-430B-915F-CDA865D7698E</gtr:id><gtr:title>Frontotemporal dementia: implications for understanding Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF677DB5-633C-472F-8933-F5B1606461B7"><gtr:id>BF677DB5-633C-472F-8933-F5B1606461B7</gtr:id><gtr:title>The role of tau in the pathological process and clinical expression of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/634b21616124fc9c9ccca1d9429ea113"><gtr:id>634b21616124fc9c9ccca1d9429ea113</gtr:id><gtr:otherNames>Vuono R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301152</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>